drugset / Trial / NCT01688531

A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

NCT01688531 ↗

Phase 1 Completed 38 enrolled Galderma R&D
RandomizedSingle-groupSingle-blindBasic science

Summary

Exploratory, international, multi-centre, randomized, investigator blinded study in acne

Timeline

Start
2012-08
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator CD0271 Unknown 0.1 % Topical
Comparator CD1579 Unknown 2.5 % Topical

Indications